Chinese Markets for Blood Disease Drugs : Market Research Report

Chinese Markets for Blood Disease Drugs

Published by: Asia Market Information & Development Company

Published: Jun. 1, 2009 - 271 Pages

I. INTRODUCTION: Report Scope and Methodology; Executive Summary
II. BUSINESS ENVIRONMENT: Economic Outlook; Key Economic Indicators; Industrial Output; Population and Labor; Foreign Investment; Foreign Trade; Financial and Tax Regulations; Banking System and Regulations; Foreign Exchange; Taxes, Tariff and Custom Duties
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS: Blood Disease Drugs Industry Structure; Market Size; Market Growth Drivers; Blood Disease Drugs Sales Volume; Major Producer Facility Locations and Sales Volume; Market Share of Key Producers; Labor Cost; Potential Entrants; Major Distributors; Major Foreign Investment; Technology Development
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND: Overview; Demand of Blood Disease Drugs by Region; Blood Disease Drugs Sales Volume; Anemia Treatment Drugs; Mecobalamin; Cobamamide; Ferrous Succinate; Leucogen; Neutropenia and Agranulocytosis Treatment Drugs; VitamineB4; Batilol; Inosine; Deoxyribonucleotide; Adrenocortical Hormone; Granulocyte Colony-Stimulating Factor(G-CSF); Leukemia Treatment Drugs Sales Volume; Interferon; Imatinib; Rituximab; Pirarubicin; Hydroxycampothecin; Other Blood Disease Drugs Sales Volume; Blood Disease Drugs Imports; Anemia Treatment Drugs; Mecobalamin; Cobamamide; Ferrous Succinate; Leucogen; Neutropenia and Agranulocytosis Treatment Drugs Imports; VitamineB4; Batilol; Inosine; Deoxyribonucleotide; Adrenocortical Hormone; Granulocyte Colony-Stimulating Factor(G-CSF); Leukemia Treatment Drugs Imports; Interferon; Imatinib; Rituximab; Pirarubicin; Hydroxycampothecin; Other Blood Disease Drugs Imports; Pricing Trends
V. BLOOD DISEASE DRUGS MARKET OUTLOOK: Blood Disease Drugs Market Outlook Overview; Government Regulation; Health Care Insurance Industry Overview; Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI. MARKETING STRATEGIES: China Market Entry Overview; China’s Distribution System; Special Rubber Distribution Channels; Transportation and Freight Infrastructure; Communications; China’s Market Entry; Export to China; Indirect export; Direct Export; License and Contract Manufacture; Assembling in China; Contract Manufacturing; Trade Permit; Investment; Equity Joint Venture; Contractual Joint Venture; Wholly Foreign-Owned Enterprise
VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY: Blood Disease Drugs Producer Profiles; Distributors and Trading Companies; Research Institutions and Associations
LIST OF TABLES
I. INTRODUCTION: Economic Outlook Summary
II. BUSINESS ENVIRONMENT: Key Economic Indicators; Industrial Output; Population and Labor Force Trends; Foreign Investment and Loans; Foreign Trade
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS: Anemia Treatment Drugs Sales Volume by Drugs Classification; Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification; Leukemia Treatment Drugs Sales Volume by Drugs Classification; Blood Disease Drugs Sales Volume; Major Producer Facility Location; Major Blood Disease Drugs Producer Sales Volume; Market Share of Key Producers; Major Foreign Investment in China
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND: Total Blood Disease Drugs Sales Volume; Blood Disease Drugs Major Producer and Their Market Share; Anemia Major Producer and Their Market Share; Anemia Treatment Drugs Sales Volume by Drugs Classification; Anemia Treatment Drugs Major Producer and Their Market Share; Mecobalamin Major Producer and Their Market Share; Cobamamide Major Producer and Their Market Share; Ferrous Succinate Major Producer and Their Market Share; Leucogen Major Producer and Their Market Share; Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share; Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification; VitamineB4 Major Producer and Their Market Share; Batilol Major Producer and Their Market Share; Inosine Major Producer and Their Market Share; Deoxyribonucleotide Major Producer and Their Market Share; Adrenocortical Hormone Major Producer and Their Market Share; Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share; Leukemia Treatment Drugs Major Producer and Their Market Share; Leukemia Treatment Drugs Sales Volume by Drugs Classification; Interferon Major Producers and Their Market Share; Imatinib Mesylate Major Producer and Their Market Share; Rituximab Major Producer and Their Market Share; Pirarubicin Major Producer and Their Market Share; Hydroxycampothecin Major Producer and Their Market Share; Blood Disease Drugs Import; Anemia Treatment Drugs Import Volume by Drugs Classification; Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification; Leukemia Treatment Drugs Import Volume by Drugs Classification
V. BLOOD DISEASE DRUGS MARKET OUTLOOK: Consumer Spending Trend; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
LIST OF CHARTS
I. NTRODUCTION: Blood Disease Drugs Sales Volume
II. BUSINESS ENVIRONMENT: China's GDP and Industrial Output; Industrial Output by Ownership; China’s Imports and Exports
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS: Anemia Treatment Drugs Sales Volume by Drugs Classification in 2008; Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification in 2008; Leukemia Treatment Drugs Sales Volume by Drugs Classification; Blood Disease Drugs Sales Volume
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND: Blood Disease Drugs Sales Volume; Worldwide Blood Disease Drugs Demand by region; Anemia Major Producer and Their Market Share; Anemia Treatment Drugs Sales Volume by Drugs Classification; Mecobalamin Sales Volume and Market Share; Cobamamide Sales Volume and Market Share; Ferrous Succinate Sales Volume and Market Share; Leucogen Sales Volume and Market Share; Neutropenia and Agranulocytosis Treatment Drugs Sales Volume and Market Share; Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification in 2008; VitamineB4 Sales Volume and Market Share; Batilol Sales Volume and Market Share; Inosine Sales Volume and Market Share

Abstract

China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Chinese Markets for Blood Disease Drugs

Table of Contents

Abstract